Results 91 to 100 of about 4,678 (171)

The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma

open access: yesNature Communications
Esophageal squamous cell carcinoma (ESCC) is highly heterogeneous. Our understanding of full molecular and immune landscape of ESCC remains limited, hindering the development of personalised therapeutic strategies.
Guozhong Jiang   +29 more
doaj   +1 more source

Image_1_Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control.TIFF

open access: yes, 2019
Cross-presenting Xcr1+CD8α DCs are attractive APCs to target for therapeutic cancer vaccines, as they are able to take up and process antigen from dying tumor cells for their MHCI-restricted presentation to CD8 T cells.
Melody A. Swartz (112385)   +5 more
core   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity

open access: yesSignal Transduction and Targeted Therapy
Severe cutaneous adverse drug reactions (SCARs) are life-threatening diseases, which are associated with human leukocyte antigen (HLA) risk variants. However, the low positive predictive values of HLA variants suggest additional factors influence disease
Lele Sun   +17 more
doaj   +1 more source

Systemic trafficking of macrophages in implant wear debris-induced periprosthetic osteolysis

open access: yesSLAS Technology
Periprosthetic osteolysis (PPOL) is a significant complication post-joint replacement, often instigated by implant wear debris, leading to chronic inflammation and bone resorption.
Mengyun Lou
doaj   +1 more source

The systemic exercise-released chemokine lymphotactin/XCL1 modulates in vitro adult hippocampal precursor cell proliferation and neuronal differentiation

open access: yes, 2019
Physical exercise has well-established anti-inflammatory effects, with neuro-immunological crosstalk being proposed as a mechanism underlying the beneficial effects of exercise on brain health. Here, we used physical exercise, a strong positive modulator
Walker, Tara L.   +7 more
core   +1 more source

Production of biologically active human lymphotactin (XCL1) by Lactococcus lactis [PDF]

open access: yes, 2009
Lymphotactin-XCL1 is a chemokine produced mainly by activated CD8? T-cells and directs migration of CD4? and CD8? lymphocytes and natural killer (NK) cells.
Franco Molina, Moisés Armides   +9 more
core   +1 more source

Neutralizing IL-38 activates γδ T cell-dependent antitumor immunity and sensitizes for chemotherapy

open access: yesJournal for ImmunoTherapy of Cancer
Background The interleukin (IL)-1-family receptor antagonist IL-38 has emerged as a negative regulator of auto-inflammation. Given the intricate interplay between antitumor immunity and auto-inflammation, we hypothesized that blocking IL-38 may enhance ...
Andreas Ernst   +9 more
doaj   +1 more source

XCL1 antiviral activity is equally effective before and after digestion of glycosaminoglycans on PBMC.

open access: yes, 2013
PBMC were incubated in the presence (‘Heparitinase-treated’) or absence (‘Untreated’) of heparitinase to digest cell surface glycosaminoglycan expression, followed by infection with HIV-1 IIIB (A) or BaL (B) in the presence of XCL1 WT (green bars), W55D (
Christina Guzzo (305744)   +7 more
core   +1 more source

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome

open access: yesBiomolecules
Objective: Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder with an increased risk for cardiovascular disease (CVD) that is enhanced by obesity.
Manjula Nandakumar   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy